Very Rare Cancer Consortium Tumor Board Meeting

May 21, 2020, 4:00pm – 6:00pm | New York Genome Center

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

Thursday, May 21, 2020
4:00 – 6:00 PM


Case Conference and Research Cohort Review

Please note registration is  required.
This will be a virtual meeting only

Introduction – Molecular and Clinical Background
Institute Cohort Review
Case Review
Critical Questions


Michael V. Ortiz, MD 
Pediatric Oncologist
Assistant Professor of Pediatrics
Memorial Sloan Kettering Cancer Center 


Brian Robinson, MD 
Chief of Surgical Pathology,
Co-Chief,  Urologic Pathology
Weill Cornell Medicine


Daniel Ramirez, MD 
Chief, Bone and Soft Tissue Pathology, Division of Anatomic Pathology, Department of Pathology and
Laboratory Medicine
Northwell Health

Helen Remotti, MD
GI, Pancreatobiliary, and Hepatic Pathology Fellowship Director
Department of Pathology and Cell Biology
Columbia University Irving Medical Center


Darrell J. Yamashiro, MD, PhD
Chief of the Division of Hematology, Oncology and Stem Cell Transplantation
Columbia University Irving Medical Center 

Patient diagnosed at age 5 with recurrence at age 21″


Carolyn Fein Levy, MD
Pediatric Hematologist/Oncologist
Assistant Professor of Pediatrics
Zucker School of Medicine at Hofstra/Northwell Health

“Twins with Wilms Tumor”


Gary Crouch, MD
Professor of Pediatrics in the Jack Martin Division of Pediatric Hematology-Oncology
Icahn School of Medicine at Mount Sinai

“Teenager with stage IV Wilms Tumor”


Katharine Offer, MD
Pediatric Hematology-Oncology, Children’s Cancer Institute,  Joseph M. Sanzari Children’s Hospital
Hackensack University Medical Center 

Beckwith–Wiedemann Syndrome – Bilateral Wilms Tumor”